StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MariMed's price to sales ratio was 0.1× on Oct 19, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 4.2×, with a median of 0.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.1×−0.1
2025Dec 31, 20250.2×−0.0
2024Dec 31, 20240.3×−0.4
2023Dec 29, 20230.7×−0.2
2022Dec 30, 20220.9×−3.3
2021Dec 31, 20214.2×+0.4
2020Dec 31, 20203.8×+0.7
2019Dec 31, 20193.1×−63.0
2018Dec 31, 201866.1×+46.7
2017Dec 29, 201719.4×+14.1
2016Dec 30, 20165.3×−2.4
2015Dec 31, 20157.6×–

More MariMed figures

See a number that looks wrong?